SciELO - Scientific Electronic Library Online

 
vol.130 número9Neuropatía por disulfiram: Comunicación de tres casos clínicosUn fondo competitivo de desarrollo para el fomento de la calidad de la educación superior en Chile índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

AGUILLON G, Juan C; CRUZAT C, Andrea; CUENCA M, Jimena  y  CUCHACOVICH T, Miguel. Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease. Rev. méd. Chile [online]. 2002, vol.130, n.9, pp.1043-1050. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872002000900013.

Cytokine unbalance is responsible for the pathogenesis of diverse inflammatory, autoimmune and infectious diseases, and Tumor Necrosis Factor Alpha (TNFa), among other cytokines, plays a central role. TNFa production can be regulated at the transcriptional, post-transcriptional, and translational levels. Variability in the promoter and coding regions of the TNFa gene may modulate the magnitude of its secretory response. Up to date, several single nucleotide polymorphisms (SNPs) have been identified in the human TNFa gene promoter. One of these, is a guanine to adenine transition at position -308, that generates the TNF1 and TNF2 alleles, respectively. The TNF2 allele is associated to a high in vitro TNF expression, and it has also been linked to an increased susceptibility and severity, for a variety of illnesses, such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, Alzheimer disease and cerebral malaria among others. It is also associated with a higher septic shock susceptibility and mortality. The investigation of polymorphisms within the TNFa cluster will be important in understanding the role of TNFa regulation in specific diseases (Rev Méd Chile 2002; 130: 1043-50).

Palabras clave : Cytokines; Polymorphism (Genetics); Tumor necrosis factor.

        · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons